BCHE and Alzheimer disease: Van Beek et al. [98] showed that AD patients treated with the cholinesterase inhibitor galantamine exhibited a greater reduction of HbO2 and total hemoglobin concentration levels compared to controls during hypotension induced by a single sit-stand task, suggesting an increased ischemic vulnerability due to impaired cortical perfusion.